FEMALE UROGENITAL DISEASES
Clinical trials for FEMALE UROGENITAL DISEASES explained in plain language.
Never miss a new study
Get alerted when new FEMALE UROGENITAL DISEASES trials appear
Sign up with your email to follow new studies for FEMALE UROGENITAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a dual immunotherapy spare the bladder in cancer patients?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab with or without relatlimab) before surgery can eliminate bladder cancer completely, allowing some patients to avoid bladder removal. About 90 adults with stage II-IIIa bladder cancer will receive the drugs and the…
Matched conditions: FEMALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: FEMALE UROGENITAL DISEASES
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC